Trends and Perspectives in the Rational Management of CNS Disorders

References

1. Li X. Feng X. Sun X. Hou N. Han F. Liu Y. Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990-2019. Front. Aging Neurosci. 2022 14 937486 10.3389/fnagi.2022.937486 36299608
   [Google Scholar]
2. Yadav E Mandal AK Sah AK Exploring the potential of herbal compounds as autophagy modulators in Alzheimer’s disease: A comprehensive review. CNS Neurol Disord Drug Targets 2026 25 2 10.2174/0118715273298025240905130205 39297466
   [Google Scholar]
3. Shome A Jha KT Chawla V Chawla PA n insight into medicinal chemistry and SAR studies of Cholinesterase and BACE-1 inhibitors for Alzheimer's disease. CNS Neurol Disord Drug Targets 2026 25 2 10.2174/0118715273315191241002115155 39415573
   [Google Scholar]
4. Kumar P Saini V Gupta D Chawla PA Kumar A BBBper: A machine learning-based online tool for Blood-Brain Barrier (BBB) permeability prediction. CNS Neurol Disord Drug Targets 2026 25 2 10.2174/0118715273328174241007060331 39415574
   [Google Scholar]
5. Hernández-Echeagaray E Vázquez-Roque R Morales-Medina JC Chlorogenic acid as a neuroprotective agent: Enhancing plasticity and promoting brain health and functional reserve. CNS Neurol Disord Drug Targets 2026 25 2 10.2174/0118715273339375250116042441 40017251
   [Google Scholar]
6. Dureshahwar K Taufique MS Investigation and mechanism of coumarin for potential anti-epileptic targets using in-vitro SH-SY5Y cell line, molecular docking, and network pharmacology-based analysis. CNS Neurol Disord Drug Targets 2026 25 2 10.2174/0118715273340950250315071352 40207767
   [Google Scholar]